Peachey J E, Naranjo C A
Drugs. 1984 Feb;27(2):171-82. doi: 10.2165/00003495-198427020-00004.
Many drugs are used in alcoholism treatment with the aim of reducing alcohol consumption and correcting alcohol-related psychosocial problems that lead to excessive drinking or result from it. Alcohol-sensitising drugs are used to reduce alcohol consumption with the expectation that improvement in other problem areas will follow. Drugs that share sedative-hypnotic actions with and cross-dependence to alcohol are often used during acute alcohol withdrawal reactions for symptomatic relief, to prevent major withdrawal symptoms, and to prevent and treat seizures. Alcohol abuse may be a form of self-medication, and treatment of an underlying psychiatric disorder, such as depression (with antidepressants), anxiety (with anxiolytics) or psychosis (with antipsychotics), is expected to reduce alcohol consumption. Pretreatment medical and psychiatric assessment of the patient is necessary to ensure that the drug therapy is appropriate to the patient's therapeutic goals and medical/psychological status. Use of the drug must be systematic and carefully monitored; the duration of treatment is determined individually for each patient on the basis of the response to the treatment as well by the development of adverse clinical effects. Ideally, the drug therapy allows the patient to establish resources necessary for continued abstinence after the drug treatment is stopped.
许多药物用于酒精中毒治疗,目的是减少酒精摄入量,并纠正与酒精相关的社会心理问题,这些问题会导致过度饮酒或由过度饮酒引发。酒精增敏药物用于减少酒精摄入量,期望随之改善其他问题领域。与酒精具有共同镇静催眠作用且存在交叉依赖性的药物,常用于急性酒精戒断反应期间以缓解症状、预防严重戒断症状以及预防和治疗癫痫发作。酒精滥用可能是一种自我治疗形式,治疗潜在的精神障碍,如抑郁症(使用抗抑郁药)、焦虑症(使用抗焦虑药)或精神病(使用抗精神病药),有望减少酒精摄入量。对患者进行治疗前的医学和精神病学评估很有必要,以确保药物治疗适合患者的治疗目标和医学/心理状况。药物的使用必须系统且仔细监测;治疗持续时间根据每位患者对治疗的反应以及不良临床效应的发展情况单独确定。理想情况下,药物治疗能让患者在药物治疗停止后建立持续戒酒所需的资源。